跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ZITHROMAX azithromycin (as dihydrate) 200mg/5mL (when reconstituted) - TGA Drug Approval Details
Approvals
/
TGA
/
ZITHROMAX azithromycin (as dihydrate) 200mg/5mL (when reconstituted)
Approved
STANDARD
ZITHROMAX azithromycin (as dihydrate) 200mg/5mL (when reconstituted)
Pfizer Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
61f9ae923f17a40c
Company
Pfizer Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
61f9ae923f17a40c
Product Name
ZITHROMAX azithromycin (as dihydrate) 200mg/5mL (when reconstituted)
Artg Id
60049
Artg Name
ZITHROMAX azithromycin (as dihydrate) 200mg/5mL (when reconstituted) powder for oral suspension bottle
Sponsor
Pfizer Australia Pty Ltd
Company Detail Path
/organization/pfizer-australia-pty-ltd
Artg Date
1997-09-05
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/5a12c9cc645531a3ece0c3aaca4c7d53.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/08db8f2f0d4cb288e026f5e8be4811e3.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
61f9ae923f17a40c
Type
Standard
Back to TGA Approvals